Exousia Bio, Inc. (LMMY)
OTCMKTS · Delayed Price · Currency is USD
0.4381
0.00 (0.00%)
Jun 5, 2026, 9:30 AM EST
Exousia Bio Revenue
In the fiscal year ending May 31, 2025, Exousia Bio had annual revenue of $3.75K, down -67.39%.
Revenue
3.75K
Revenue Growth
-67.39%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
23.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 3.75K | -7.75K | -67.39% |
| May 31, 2024 | 11.50K | - | - |
| May 31, 2023 | - | - | - |
| May 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionExousia Bio News
- 8 months ago - Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms - Accesswire
- 8 months ago - LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. - GlobeNewsWire
- 9 months ago - Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value - Accesswire
- 1 year ago - LAMY Inc. Accelerates Strategic Upgrades, Deepens Global Presence and Technological Innovation - Accesswire
- 1 year ago - LAMY Unveils GenZ Financial Literacy Initiative Powered by User-Generated Content and Creator Economy Tools - Accesswire
- 1 year ago - LAMY Discusses The Smart Education Market Entering a Golden Era of Growth - Accesswire
- 1 year ago - L A M Y Announces Groundbreaking Advancements, Leading the Future of Education-Gaming Integration - Accesswire